Cargando…

Severe hypersensitivity reaction to etoposide phosphate: A case report

Hypersensitivity to etoposide phosphate has rarely been documented. We report a case of severe hypersensitivity reaction to etoposide phosphate in an old man. The patient experienced anaphylactic shock and has been hospitalized in intensive care unit. Vigilance is required regarding potential severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotteret, Camille, Rousseau, Julia, Zribi, Kaouther, Schlatter, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495780/
https://www.ncbi.nlm.nih.gov/pubmed/32983504
http://dx.doi.org/10.1002/ccr3.2732
_version_ 1783582959162359808
author Cotteret, Camille
Rousseau, Julia
Zribi, Kaouther
Schlatter, Joel
author_facet Cotteret, Camille
Rousseau, Julia
Zribi, Kaouther
Schlatter, Joel
author_sort Cotteret, Camille
collection PubMed
description Hypersensitivity to etoposide phosphate has rarely been documented. We report a case of severe hypersensitivity reaction to etoposide phosphate in an old man. The patient experienced anaphylactic shock and has been hospitalized in intensive care unit. Vigilance is required regarding potential severe reactions with etoposide phosphate formulation.
format Online
Article
Text
id pubmed-7495780
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74957802020-09-25 Severe hypersensitivity reaction to etoposide phosphate: A case report Cotteret, Camille Rousseau, Julia Zribi, Kaouther Schlatter, Joel Clin Case Rep Case Reports Hypersensitivity to etoposide phosphate has rarely been documented. We report a case of severe hypersensitivity reaction to etoposide phosphate in an old man. The patient experienced anaphylactic shock and has been hospitalized in intensive care unit. Vigilance is required regarding potential severe reactions with etoposide phosphate formulation. John Wiley and Sons Inc. 2020-08-06 /pmc/articles/PMC7495780/ /pubmed/32983504 http://dx.doi.org/10.1002/ccr3.2732 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Cotteret, Camille
Rousseau, Julia
Zribi, Kaouther
Schlatter, Joel
Severe hypersensitivity reaction to etoposide phosphate: A case report
title Severe hypersensitivity reaction to etoposide phosphate: A case report
title_full Severe hypersensitivity reaction to etoposide phosphate: A case report
title_fullStr Severe hypersensitivity reaction to etoposide phosphate: A case report
title_full_unstemmed Severe hypersensitivity reaction to etoposide phosphate: A case report
title_short Severe hypersensitivity reaction to etoposide phosphate: A case report
title_sort severe hypersensitivity reaction to etoposide phosphate: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495780/
https://www.ncbi.nlm.nih.gov/pubmed/32983504
http://dx.doi.org/10.1002/ccr3.2732
work_keys_str_mv AT cotteretcamille severehypersensitivityreactiontoetoposidephosphateacasereport
AT rousseaujulia severehypersensitivityreactiontoetoposidephosphateacasereport
AT zribikaouther severehypersensitivityreactiontoetoposidephosphateacasereport
AT schlatterjoel severehypersensitivityreactiontoetoposidephosphateacasereport